SIA
TEVA icon

Schechter Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Schechter Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,303
Closed -$227K – 686
2024
Q4 		$227K Sell
10,303
-1,399
-12% -$25.5K 0.02% 549
2024
Q3 		$211K Buy
11,702
+113
+1% +$1.98K 0.02% 579
2024
Q2 		$188K Buy
11,589
+161
+1% +$2.48K 0.01% 575
2024
Q1 		$161K Buy
11,428
+243
+2% +$3.06K 0.01% 587
2023
Q4 		$117K Buy
+11,185
New +$104K 0.01% 577

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Schechter Investment Advisors's TEVA Position: Q1 2025 in Review

Schechter Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2025, closing a stake of 10,303 shares — an estimated $227K sold.

Schechter Investment Advisors first reported a position in TEVA in Q4 2023 and held it in 5 quarters. The position peaked at $227K in Q4 2024. 560 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • Schechter Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Schechter Investment Advisors sold 10,303 Teva Pharmaceuticals shares in Q1 2025, an estimated $227K.
  • Schechter Investment Advisors first reported a position in Teva Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Schechter Investment Advisors's Teva Pharmaceuticals position peaked at $227K in Q4 2024.
  • 560 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.